NEW YORK, NY — On the evening of October 13, 2026, the global skyline will undergo a dramatic transformation. From the towering heights of One World Trade Center in Manhattan to the historic arches of Philadelphia’s City Hall and the mist-covered precipice of Niagara Falls, more than 325 landmarks across 20 countries will be bathed in a specific triad of colors: teal, green, and pink.
This is not merely a decorative display; it is the visual vanguard of the #LightUpMBC campaign, a global initiative spearheaded by METAvivor Research and Support. The event coincides with National Metastatic Breast Cancer (MBC) Awareness Day, a date designed to pivot the conversation from general breast cancer awareness toward the specific, life-critical needs of those living with Stage 4 disease.
While October is traditionally associated with the "pink ribbon" and messages of early detection, the #LightUpMBC campaign seeks to highlight a harsher reality: metastatic breast cancer remains incurable. By illuminating the world’s most recognizable structures, METAvivor aims to bridge the gap between awareness and action, raising millions of dollars for the research necessary to turn a terminal diagnosis into a manageable, chronic condition.
Main Facts: A Global Beacon for the "Forgotten" Stage
Metastatic breast cancer, also known as Stage 4, occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to settle in distant organs—most commonly the bones, liver, lungs, or brain. Despite advances in medical technology, once breast cancer has metastasized, the five-year survival rate drops significantly, and the disease is currently considered terminal.
The #LightUpMBC campaign is unique in its scale and focus. In 2026, the initiative has reached an unprecedented milestone:
- Breadth of Participation: More than 325 landmarks are confirmed to participate, spanning all 50 U.S. states and 195 cities worldwide.
- International Reach: Landmarks in the Philippines, Scotland, Canada, and beyond will join the effort, signaling a truly global coalition.
- The Signature Event: The campaign culminates in #LightUpMBC Live, a virtual broadcast at 8 p.m. ET / 5 p.m. PT. The program features a blend of patient testimonials, scientific updates, and performances by Broadway stars.
- The Mission: 100% of the net proceeds from the campaign are funneled directly into Stage 4 research grants. METAvivor remains the only U.S. organization dedicated exclusively to funding MBC research.
The choice of colors—teal, green, and pink—is intentional and symbolic. Teal represents healing and spirituality; green symbolizes the triumph of spring over winter and the renewal of life; and pink represents the breast cancer origin. Together, they form the MBC awareness ribbon, a stark contrast to the solitary pink ribbon that dominates the rest of the month.
Chronology: From a Single Bridge to a Global Phenomenon
The meteoric rise of #LightUpMBC is a testament to the power of grassroots advocacy. The movement did not begin in a corporate boardroom but rather from a personal wish for visibility.
2017: The First Light
The campaign was founded by Laura Inahara, inspired by her best friend, Jessica Moore. Jessica was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later. Her simple hope was to see a single local landmark lit in the MBC colors to acknowledge those living with the disease. In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to "Light Up" for MBC.
2018–2020: National Expansion
Following the success in New Hampshire, the campaign gained traction across the United States. Advocacy groups and families of "METAvivors" began petitioning their local city councils and building managers. By 2019, dozens of landmarks were participating. When the COVID-19 pandemic hit in 2020, the campaign pivoted to include a digital livestream, #LightUpMBC Live, allowing the community to connect safely while maintaining the momentum of the movement.
2021–2025: Reaching the $2.7 Million Milestone
Over the last five years, the campaign evolved into a sophisticated fundraising machine. By integrating celebrity performances and high-level scientific discourse into its annual broadcast, #LightUpMBC has raised over $2.7 million for research to date. It has successfully petitioned iconic structures like the Willis Tower in Chicago and the Mactan-Cebu Airport in the Philippines to join the cause.
2026: The Current Landscape
Today, the campaign is a staple of the October calendar. The 2026 iteration is the largest in history, reflecting a growing public understanding that "awareness" of breast cancer is no longer enough—funding for the most lethal form of the disease is the new priority.
Supporting Data: The Stark Reality of MBC in 2026
To understand why #LightUpMBC is necessary, one must look at the epidemiological data provided by the National Cancer Institute (NCI) and the Surveillance, Epidemiology, and End Results (SEER) program.
Mortality and Diagnosis
In 2026, an estimated 42,670 people in the United States are expected to die from breast cancer. This averages out to approximately 117 deaths every single day. Crucially, nearly all of these deaths are the result of metastatic disease.
While many patients are diagnosed at Stage 4 from the outset (de novo metastatic breast cancer), a significant portion of the MBC community consists of individuals who were previously treated for early-stage cancer. Metastasis can occur months, years, or even decades after a patient has been told they are "cancer-free" or "in remission."
The Funding Gap
A primary driver of METAvivor’s mission is the historical disparity in research funding. Advocacy groups have long pointed out that while billions are raised annually for breast cancer, only an estimated 7% to 10% of those funds are traditionally directed toward researching metastatic disease. The vast majority of funding is historically allocated toward prevention, early detection, and primary treatment.
METAvivor’s model disrupts this by ensuring that 100% of donations (after essential costs) go toward Stage 4 research. This focus is critical because the biology of a metastatic tumor is often different from the primary tumor, requiring specialized therapies that do not yet exist.
Treatment Dynamics
For the MBC patient, treatment is a permanent fixture of life. Even when a scan shows "No Evidence of Disease" (NED), the cancer is not considered cured; it is merely being held at bay. The goal of current research is to extend the time a patient can stay on a specific line of treatment before the cancer develops resistance, necessitating a shift to a new, often more aggressive, therapy.
Official Responses: Voices from the Front Lines
The 2026 campaign is bolstered by the voices of those who live with the disease and those who study it.
Dr. Kelly Shanahan, the Board President of METAvivor, offers a unique perspective as both a physician and a patient. "When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, the campaign’s founder, emphasizes the legacy of her late friend. "Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love… and has now raised over $2.7 million for critical MBC research."
The 2026 livestream will be hosted by Tami Eagle Bowling and Kara Lindsay. Bowling, who has lived with MBC for 11 years, has been a driving force in professionalizing the #LightUpMBC Live broadcast. The inclusion of Broadway talent—such as Tony Award winner Victoria Clark and Tony nominee Dorian Harewood—underscores the campaign’s ability to command mainstream cultural attention.
From a scientific standpoint, the program will feature experts who explain how METAvivor-funded grants are currently exploring immunotherapy, targeted therapies, and the genetic drivers of metastasis. These researchers argue that the "terminal" label is a hurdle that can only be cleared through aggressive, well-funded laboratory work.
Implications: Changing the Narrative of Breast Cancer
The #LightUpMBC campaign represents a fundamental shift in how society views breast cancer. For decades, the narrative has been one of "winning the battle" and "survivorship." While these stories are inspiring, they often leave those with Stage 4 feeling isolated or like "failures" of the system.
Psychological and Social Impact
By lighting up 325 landmarks, the campaign provides a powerful psychological boost to patients. Seeing a city’s skyline reflect their specific struggle validates their experience. It tells the MBC community that they are seen and that their lives are worth the investment of research dollars.
The Shift to "Chronic Disease"
The ultimate implication of the #LightUpMBC movement is the potential reclassification of Stage 4 breast cancer. If research can continue to identify new pathways to stop tumor growth, MBC could follow the trajectory of HIV/AIDS—moving from a guaranteed death sentence to a chronic, manageable condition that allows patients to live for decades with a high quality of life.
Call to Action
As the sun sets on October 13, 2026, the public is encouraged to do more than just watch. METAvivor is calling on citizens to photograph the illuminated landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor. This digital "wave" of teal, green, and pink serves to educate the uninformed and drive donors to the campaign’s website.
The 2026 campaign stands as a reminder that while early detection is important, it is not a guarantee. For the 117 people who will die today, and the thousands more living with the uncertainty of Stage 4, the lights across the globe represent a beacon of hope—and a demand for a cure.
For more information on participating landmarks, to view the livestream, or to make a donation toward metastatic breast cancer research, visit www.lightupmbc.org.
About the Author
